CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan Innoviva - INVA CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 11.57-20.71
Average Volume (10 days) 607.28K
Average Volume (3 months) 12.32M
Market Cap 904.39M
P/E Ratio 4.06
Shares Outstanding 69.78M
Revenue 373.22M
EPS 3.19
Dividend (Yield %) N/A
Beta 0.55
Next Earnings Date Feb 7, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Innoviva Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 133.569 217.217 261.004 261.016 336.794 391.866
Revenue 133.569 217.217 261.004 261.016 336.794 391.866
Total Operating Expense 24.581 33.613 22.753 14.656 15.671 16.763
Selling/General/Admin. Expenses, Total 23.188 32.258 22.753 14.656 13.883 16.187
Research & Development 1.393 1.355 0 0 1.788 0.576
Operating Income 108.988 183.604 238.251 246.36 321.123 375.103
Interest Income (Expense), Net Non-Operating -51.834 -42.29 -22.294 -13.12 33.47 73.799
Other, Net 2.382 -7.042 -5.702 -0.345 -0.348 -3.626
Net Income Before Taxes 59.536 134.272 210.255 232.895 354.245 445.276
Net Income After Taxes 59.536 134.272 406.328 190.993 293.814 368.837
Net Income Before Extra. Items 59.536 134.143 395.056 157.288 224.402 265.854
Total Extraordinary Items 0 0 0
Net Income 59.536 134.143 395.056 157.288 224.402 265.854
Income Available to Common Excl. Extra. Items 59.536 134.143 395.056 157.288 224.402 265.854
Income Available to Common Incl. Extra. Items 59.536 134.143 395.056 157.288 224.402 265.854
Diluted Net Income 59.536 134.143 395.056 157.288 229.119 270.59
Diluted Weighted Average Shares 123.233 119.866 113.408 113.409 113.554 94.31
Diluted EPS Excluding Extraordinary Items 0.48312 1.11911 3.48349 1.38691 2.01771 2.86915
Diluted Normalized EPS 0.48312 1.11911 3.48349 1.38691 2.01771 2.86915
Minority Interest -0.129 -11.272 -33.705 -69.412 -102.983
Dilution Adjustment 4.717 4.736
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 85.518 100.806 97.862 107.68 90.059
Revenue 85.518 100.806 97.862 107.68 90.059
Total Operating Expense 6.035 4.266 3.309 3.153 32.992
Selling/General/Admin. Expenses, Total 5.986 4.228 2.86 3.113 6.492
Research & Development 0.049 0.038 0.449 0.04 5.838
Operating Income 79.483 96.54 94.553 104.527 57.067
Interest Income (Expense), Net Non-Operating 50.381 40.59 29.276 -46.448 -12.099
Other, Net -0.433 -0.951 -0.652 -1.59 -0.25
Net Income Before Taxes 129.431 136.179 123.177 56.489 44.718
Net Income After Taxes 109.695 110.846 102.646 45.65 37.858
Minority Interest -15.572 -21.898 -30.208 -35.305 -22.085
Net Income Before Extra. Items 94.123 88.948 72.438 10.345 15.773
Net Income 94.123 88.948 72.438 10.345 15.773
Income Available to Common Excl. Extra. Items 94.123 88.948 72.438 10.345 15.773
Income Available to Common Incl. Extra. Items 94.123 88.948 72.438 10.345 15.773
Dilution Adjustment 1.204 1.163 1.186 1.183 2.569
Diluted Net Income 95.327 90.111 73.624 11.528 18.342
Diluted Weighted Average Shares 113.624 100.639 81.699 81.632 93.73
Diluted EPS Excluding Extraordinary Items 0.83897 0.89539 0.90116 0.14122 0.19569
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.83897 0.89539 0.90116 0.14122 0.38231
Unusual Expense (Income) 20.662
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 198.046 200.369 199.043 431.234 342.058 313.673
Cash and Short Term Investments 150.433 129.075 114.908 350.845 246.487 201.525
Cash & Equivalents 118.016 73.336 62.417 278.096 246.487 201.525
Short Term Investments 32.417 55.739 52.491 72.749 0
Total Receivables, Net 46.847 70.54 83.286 79.427 93.931 110.711
Accounts Receivable - Trade, Net 46.847 70.54 83.286 79.427 93.931 110.711
Prepaid Expenses 0.766 0.754 0.849 0.962 1.64 1.437
Total Assets 378.996 367.337 548.193 724.826 999.57 926.395
Property/Plant/Equipment, Total - Net 0.368 0.209 0.16 0.033 0.028 0.012
Intangibles, Net 180.545 166.722 152.899 139.076 125.253 111.43
Other Long Term Assets, Total 0.037 0.037 196.091 154.483 93.973 17.435
Total Current Liabilities 20.049 34.742 5.7 5.371 6.11 5.807
Accounts Payable 0.128 0.601 0.011 0.01 0.066 0.027
Accrued Expenses 11.284 9.141 5.689 5.361 6.044 5.78
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7.752 25 0
Other Current Liabilities, Total 0.885 0
Total Liabilities 731.987 610.196 394.61 411.331 459.658 511.652
Total Long Term Debt 708.341 574.362 382.855 377.12 385.517 394.653
Long Term Debt 708.341 574.362 382.855 377.12 385.517 394.653
Other Liabilities, Total 3.597 0.94 0.586 0.219 0.106 0
Total Equity -352.991 -242.859 153.583 313.495 539.912 414.743
Preferred Stock - Non Redeemable, Net 0 0 0 0 0 0
Common Stock 1.085 1.019 1.011 1.013 1.014 0.696
Additional Paid-In Capital 1282.08 1258.15 1256.27 1258.86 1260.9 1264.02
Retained Earnings (Accumulated Deficit) -1632.89 -1498.75 -1103.69 -946.404 -722.002 -456.148
Treasury Stock - Common -3.263 -3.263 0 -393.829
Other Equity, Total 0.001 -0.018 -0.003 0.027 0
Total Liabilities & Shareholders’ Equity 378.996 367.337 548.193 724.826 999.57 926.395
Total Common Shares Outstanding 108.435 101.896 101.098 101.288 101.392 69.5655
Minority Interest 0.152 5.469 28.621 67.925 111.192
Long Term Investments 438.258 483.845
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 372.933 148.261 236.928 313.673 317.823
Cash and Short Term Investments 282.89 43.265 135.115 201.525 216.802
Cash & Equivalents 282.89 43.265 135.115 201.525 216.802
Total Receivables, Net 88.974 104.262 101.271 110.711 93.515
Accounts Receivable - Trade, Net 88.974 104.262 101.271 110.711 93.515
Prepaid Expenses 1.069 0.734 0.542 1.437 5.576
Total Assets 1088.29 789.15 887.239 926.395 1107.47
Property/Plant/Equipment, Total - Net 0.024 0.019 0.015 0.012 3.985
Intangibles, Net 121.797 118.341 114.885 111.43 212.974
Long Term Investments 519.325 473.677 507.116 483.845 544.437
Other Long Term Assets, Total 74.211 48.852 28.295 17.435 22.711
Total Current Liabilities 3.804 5.371 3.125 5.807 109.227
Accounts Payable 0.014 0.03 0.089 0.027 1.808
Accrued Expenses 3.79 5.341 3.036 5.78 11.403
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 453.829 459.37 484.428 511.652 720.832
Total Long Term Debt 387.728 389.989 392.295 394.653 442.731
Long Term Debt 387.728 389.989 392.295 394.653 442.731
Minority Interest 62.22 63.965 88.994 111.192 165.575
Other Liabilities, Total 0.077 0.045 0.014 0 3.299
Total Equity 634.461 329.78 402.811 414.743 386.642
Common Stock 1.014 0.695 0.695 0.696 0.696
Additional Paid-In Capital 1261.33 1261.84 1262.44 1264.02 1182.91
Retained Earnings (Accumulated Deficit) -627.879 -538.931 -466.493 -456.148 -403.137
Total Liabilities & Shareholders’ Equity 1088.29 789.15 887.239 926.395 1107.47
Total Common Shares Outstanding 101.408 69.495 69.492 69.5655 69.594
Preferred Stock - Non Redeemable, Net 0 0 0 0
Treasury Stock - Common -393.829 -393.829 -393.829 -393.829
Other Current Assets, Total 1.93
Goodwill, Net 5.544
Current Port. of LT Debt/Capital Leases 96.016
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 59.536 134.272 406.328 190.993 293.814 368.837
Cash From Operating Activities 60.984 141.749 223.531 257.458 313.113 363.813
Cash From Operating Activities 13.954 13.982 13.872 13.874 13.84 13.832
Non-Cash Items 9.458 21.775 16.145 7.621 -40.639 -78.415
Cash Interest Paid 48.797 40.353 17.861 10.974 9.933 9.933
Changes in Working Capital -21.964 -28.28 -16.76 3.095 -14.322 -16.873
Cash From Investing Activities -4.58 -23.236 3.519 -18.003 -314.937 43.722
Capital Expenditures -0.278 0 0 -0.012 -0.013 0
Other Investing Cash Flow Items, Total -4.302 -23.236 3.519 -17.991 -314.924 43.722
Cash From Financing Activities -97.568 -163.193 -237.969 -23.776 -29.785 -452.497
Financing Cash Flow Items 0.578 0.023 -5.955 -10.553 -30.129 -59.457
Total Cash Dividends Paid -0.96 -0.281 -0.08 -0.011 0 0
Issuance (Retirement) of Stock, Net -78.788 -99.193 -1.934 0.538 0.344 -393.04
Issuance (Retirement) of Debt, Net -18.398 -63.742 -230 -13.75 0 0
Net Change in Cash -41.164 -44.68 -10.919 215.679 -31.609 -44.962
Deferred Taxes -196.054 41.875 60.42 76.432
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 109.695 220.541 323.187 368.837 37.858
Cash From Operating Activities 84.107 168.721 265.432 363.813 98.102
Cash From Operating Activities 3.46 6.918 10.376 13.832 3.501
Deferred Taxes 19.736 45.069 65.6 76.432 6.86
Non-Cash Items -52.003 -93.637 -124.495 -78.415 31.684
Cash Interest Paid 4.967 4.967 9.933 9.933 5.411
Changes in Working Capital 3.219 -10.17 -9.236 -16.873 18.199
Cash From Investing Activities -26.394 63.627 63.627 43.722 -143.156
Capital Expenditures 0 0 0 0 -0.009
Other Investing Cash Flow Items, Total -26.394 63.627 63.627 43.722 -143.147
Cash From Financing Activities -21.31 -435.57 -440.431 -452.497 60.331
Financing Cash Flow Items -21.285 -41.446 -46.358 -59.457 -6.507
Issuance (Retirement) of Stock, Net -0.025 -394.124 -394.073 -393.04 0.214
Net Change in Cash 36.403 -203.222 -111.372 -44.962 15.277
Total Cash Dividends Paid 0
Issuance (Retirement) of Debt, Net 0 66.624
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 13.539 9447948 79542 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 10.0125 6987044 27003 2022-09-30 LOW
Sarissa Capital Management, L.P. Hedge Fund 9.4779 6614000 0 2022-09-30 LOW
Putnam Investment Management, L.L.C. Investment Advisor/Hedge Fund 7.0958 4951669 1235940 2022-09-30 LOW
Renaissance Technologies LLC Hedge Fund 6.1128 4265673 -533300 2022-09-30 HIGH
Westfield Capital Management Company, L.P. Investment Advisor/Hedge Fund 5.675 3960168 528481 2022-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 4.2075 2936119 237843 2022-09-30 LOW
LSV Asset Management Investment Advisor 3.9575 2761703 -449275 2022-09-30 LOW
Millennium Management LLC Hedge Fund 3.5882 2503972 1178325 2022-09-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.5408 2470894 13786 2022-09-30 LOW
Systematic Financial Management, L.P. Investment Advisor 2.6349 1838741 388755 2022-09-30 LOW
Assenagon Asset Management S.A. Investment Advisor 2.4546 1712874 -190058 2022-12-31 HIGH
Pacer Advisors, Inc. Investment Advisor 2.1143 1475398 371034 2022-09-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6479 1149935 14055 2022-09-30 LOW
FundLogic SAS Investment Advisor/Hedge Fund 1.5189 1059944 0 2022-09-30 HIGH
Goldman Sachs & Company, Inc. Research Firm 1.4152 987591 51769 2022-09-30 MED
D. E. Shaw & Co., L.P. Hedge Fund 1.336 932321 -221413 2022-09-30 MED
Citadel Advisors LLC Hedge Fund 1.2008 837944 237602 2022-09-30 HIGH
BofA Global Research (US) Research Firm 0.9691 676268 -1238955 2022-09-30 LOW
Nuveen LLC Pension Fund 0.8862 618444 -346071 2022-09-30 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+485000+

Trader

65000+

Klien aktif per bulan

$48000000+

Volume investasi per bulan

$28000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Pharmaceuticals (NEC)

1350 Old Bayshore Highway
Suite 400
BURLINGAME
CALIFORNIA 94010
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Biaya inap posisi Long -0.0223%
Biaya inap posisi short 0.0065%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Biaya inap posisi Long -0.1138%
Biaya inap posisi short 0.0796%
Waktu biaya inap 22:00 (UTC)
Spread 0.005

US100

12,566.80 Price
-0.450% 1D Chg, %
Biaya inap posisi Long -0.0183%
Biaya inap posisi short 0.0071%
Waktu biaya inap 22:00 (UTC)
Spread 3.0

XRP/USD

0.41 Price
+0.450% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 0.00300

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda